Nurse Practitioner

Strive Health is recognized by TIME as one of the World's Top HealthTech Companies for a second consecutive year. DENVER - Sept. 17, 2026 - Strive Health, the leading U.S. value-based kidney care company, was named one of the World's Top HealthTech Companies by TIME and Statista Inc. for a second consecutive year. The full award list can be viewed on TIME.com. The World's Top HealthTech Companies 2026 ranking recognizes leading innovators that are advancing healthcare with the support of technology. Out of thousands of healthcare technology companies reviewed, the top 500 were honored. Companies were evaluated based on three primary data sources: financial performance metrics, reputation analysis and online engagement. "This TIME recognition reflects the work the entire Strive Health team is doing to make kidney care simpler, more connected and patient-centered," said Tom Hawkes, Chief Technology Officer at Strive Health. "By bringing together data and insights, our technology enables care teams and provider partners to spend less time searching for information and more time delivering proactive, personalized support to people living with kidney disease." Strive Health's technology connects clinical data, care teams, specialty partners and PCPs to support more coordinated kidney care. It gives providers timely insights and makes referrals, updates and follow-through more seamless across the care network, helping clinicians identify changing needs sooner and connect patients to the right care. Today, Strive Health serves more than 165,000 patients across all 50 states, partners with over 6,500 providers and has $5.5 billion of medical spend under management. The company's strong clinical outcomes were recently published in two evidence-based, peer-reviewed journals. A study of Strive Health's Transitions of Care Management program, published in the Journal of Patient Experience, found that the program was associated with 42%, 37%, and 25% lower hospital readmission rates at 7, 14, and 30 days, respectively. Strive Health's study published in The American Journal of Managed Care that focused on eGFR - a calculation used to check how well the kidneys are filtering waste from the blood - showed a 77% slower decline in stage 3b chronic kidney disease (CKD) and a 65% slower decline in stage 4 CKD. To date, Strive Health has been recognized with more than 15 awards, including LinkedIn Top Startup in Denver, Built In Best Companies, CB Insights 50 Most Promising Digital Health Companies and more. ABOUT STRIVE HEALTH Strive Health is the nation's leader in value-based kidney care and partner of choice for innovative healthcare payors and providers. Using a unique combination of technology - including AI - care interventions and seamless integration with local providers, Strive forms an integrated care delivery system that supports the entire patient journey from chronic kidney disease (CKD) to end-stage kidney disease (ESKD). To help patients, Strive partners with commercial and Medicare Advantage payors, Medicare, health systems and physicians through flexible value-based payment arrangements, including risk-based programs. Strive serves over 165,000 people with CKD and ESKD across 50 states and partners with over 6,500 providers. Strive's case management and population health programs are accredited by the National Committee for Quality Assurance (NCQA), and its technology platform, CareMultiplier(TM), is certified by HITRUST. To learn more, visit StriveHealth.com. MEDIA CONTACT: Nicole Leatherman Strive Health Communications 619-917-4807 [email protected]

Strive Health adds Jamie Sharp and Chris Rigg to executive team. June 16, 2026 Jamie Sharp And Chris Rigg Strive Health, a national provider of value-based kidney care services, has expanded its executive leadership team with the appointments of Dr. Jamie Sharp as Chief Medical Officer and Chris Rigg as Chief Financial Officer. The additions come as the company continues to scale its value-based care model nationwide and invest in technology-driven approaches to managing chronic kidney disease. Sharp will oversee Strive's clinical strategy and performance, while Rigg will lead financial strategy and operations, supporting the company's growth initiatives and deployment of artificial intelligence technologies across the organization. "As we continue to build on Strive's strong momentum, Jamie and Chris stood out as the right leaders for this moment," said Paul Marchetti, president of Strive Health. "They bring track records of success and execution that will help us strengthen our performance-based culture, keep evolving our clinical model and build on the results-oriented ways of working that continue to drive Strive's success." Sharp joins Strive from dementia care provider Rippl, where she served as Chief Medical Officer and helped advance a value-based care approach supported by technology-enabled care delivery. Her previous leadership roles include senior positions at Aetna, a CVS Health company, as well as naviHealth and Evolent Health, organizations known for their focus on population health management and care coordination. At Strive, Sharp will help advance clinical outcomes and continue refining the company's integrated care model, which addresses the complex needs of patients living with chronic kidney disease and related conditions. "Chronic illnesses such as kidney disease, diabetes, heart disease and hypertension affect three out of four adults and account for about 90% of healthcare spending," Sharp said. "Treating kidney disease is not a singular issue. Patients are often navigating multiple complex conditions that require comprehensive care and coordination. I look forward to contributing to the holistic, integrated approach to supporting patients throughout their healthcare journey." The appointment comes as healthcare providers and payers increasingly seek coordinated care models that can improve outcomes while reducing costs for patients with chronic diseases. Kidney disease patients often require management across multiple specialties, making care coordination and population health infrastructure central to value-based care strategies. Rigg brings a combination of healthcare finance, insurance and capital markets experience to the company. Most recently, he served as Chief Financial Officer and Senior Vice President of Commercial Health Benefits at Elevance Health, where he led financial strategy and performance for the organization's commercial health plan business serving more than 32 million consumers through individual and employer-sponsored products. In his new role, Rigg will oversee Strive's financial operations, support value-based risk contracting initiatives and help build the infrastructure needed to support continued growth. His responsibilities will also include aligning financial strategy with the company's operational and technology investments as it expands nationally. Earlier in his career, Rigg worked as an equity research analyst at Deutsche Bank, Susquehanna International Group and Merrill Lynch, where he advised investors on healthcare services, managed care and value-based care markets. His experience analyzing healthcare business models and emerging industry trends is expected to support Strive's efforts to scale its operations and deepen partnerships with payers and providers. "Joining Strive gives me the opportunity to bring a strategic financial perspective to the company's partnerships and guide initiatives, ultimately driving better outcomes for patients and providers," Rigg said. "I'm committed to help advance the long-term evolution of kidney care in the U.S. through my work at Strive." Chris Riopelle, co-founder and chief executive officer of Strive Health, said the appointments will help strengthen the company's ability to deliver measurable results as it expands its value-based kidney care platform. "Sharp and Rigg's leadership will help accelerate Strive's ability to deliver measurable outcomes for patients, providers and payers as Strive continues to expand its value-based kidney care model nationwide," Riopelle said. Strive Health serves more than 150,000 people with chronic kidney disease and end-stage kidney disease across all 50 states and partners with more than 6,500 healthcare providers. The company combines technology, including artificial intelligence, with care management and local provider integration to support patients throughout the progression of kidney disease. Through partnerships with commercial insurers, Medicare Advantage plans, health systems and physicians, Strive delivers care through a range of value-based payment arrangements designed to improve outcomes while managing costs.

Strive Health, a national leader in value-based kidney care, has appointed Jamie Sharp as chief medical officer and Chris Rigg as chief financial officer to its executive team. Sharp previously served as chief medical officer at Rippl and held senior roles at Aetna, naviHealth and Evolent Health. She will oversee Strive's clinical strategy and performance, focusing on integrated care for patients managing multiple chronic conditions including kidney disease, diabetes and heart disease. Rigg joins from Elevance Health, where he was chief financial officer and senior vice president of Commercial Health Benefits, supporting over 32 million consumers. He will drive financial strategy and help scale the business whilst deploying AI technologies. Strive Health serves over 150,000 people with chronic and end-stage kidney disease across 50 states, partnering with more than 6,500 providers.